Guangxi Yunbo Health Technology Co., Ltd. selected as Guangxi Gazelle Company
According to reports (by Tian Xixia, Trainee Reporter from Guangxi Cloud - Guangxi Daily) on October 30, the Department of Science and Technology of Guangxi Zhuang Autonomous Region announced the list of 2024 Guangxi Gazelle Company. Guangxi Yunbo Health Technology Co., Ltd., a subsidiary of China-Malaysia Investment Holding Group (GCMG), was successfully selected, becoming the first gazelle enterprise to be recognized in the group. Previously, Guangxi Yunbo Health Technology Co., Ltd. has successively won the title of National High-tech Enterprise and the title of Specialized and Innovative Enterprise of Guangxi Zhuang Autonomous Region.
Since the beginning of this year, the production and sales of Yunbo’s knock-out products have been booming, and the export volume has increased significantly. By the end of September, Yunbo’s product exports had increased by more than 50% year on year, and export sales revenue had increased by more than 200% year on year. In addition, Yunbo has continued to improve its product research and development capabilities, and the project of “R&D and Production of High-strength Direct Pressure Calcium Phosphate Granules” won the first prize of the Growth Enterprise Group of Qinzhou Science and Technology Entrepreneurship Competition. It was recommended by the Department of Science and Technology of Guangxi Zhuang Autonomous Region to participate in the 13th China Innovation and Entrepreneurship Competition.
In recent years, focusing on the development of maritime industries and the direction of "4+X" industrial investment, GCMG has vigorously invested in scientific and technological innovation, strategic emerging industries and future industries, and helped the growth and development of technology-based enterprises from multiple dimensions such as capital empowerment, policy empowerment and management empowerment. Moving forward, GCMG will continue to focus on capital empowerment and innovation-driven development, increase investment and cultivation of unicorn enterprises, wildebeest enterprises, gazelle enterprises, and specialized and new “little giant” enterprises, give full play to the leading role of state-owned capital, and help the industrial transformation and upgrading and the development and growth of strategic emerging industries.